New cancer plan urged as survival improvements in England slow
It found substantial improvements over the 48-year period, with the five-year survival index increasing from 28.8 percent in 1971–72 to 56.6 percent in 2018.
However, the pace of progress has slowed in recent years.
The 10-year survival index improved by four percent between 2000–01 and 2005–06 and only 1.4 percent between 2010–11 and 2015–16.
The slowdown since 2010 "is likely to be at least partly explained by longer waits for diagnosis and treatment," said the report.
The deceleration has been observed across many individual cancers, "implying a system-wide challenge," said the study, funded by the Cancer Research UK charity.
Most notably, the 10-year survival index for breast, cervix, rectum, prostate, testis, and uterus cancers plateaued in the last 10–15 years, while the index for larynx cancers decreased.
Pancreatic cancer survival, at 4.3 percent in 2018, has shown minimal change since 1971–72.
The study calls for a "new, long-term National Cancer Plan" to "bring cancer survival trends back towards the best in the world".
National cancer strategies have been part of health policy in England and Wales since 2000.
The fourth national cancer strategy was published in 2015 but is now considered outdated as the current trajectory has failed to match its ambitious targets.
Plans for a fifth plan were withdrawn in January 2023, "leaving England as one of the few high-income countries in which a national cancer plan was not a central pillar of national health policy," said the report.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
France 24
2 days ago
- France 24
Cowboys owner Jones says experimental drug saved him after cancer diagnosis
Jones, 82, talked about undergoing cancer treatments in an episode of the upcoming Netflix documentary on the Cowboys: "America's team: The Gambler and His Cowboys". He didn't give details, but a reporter from the Morning News asked him about it on Tuesday and Jones said he was "saved by a fabulous treatment and great doctors and a real miracle (drug) called PD-1 (therapy). "I went into trials for that PD-1 and it has been one of the great medicines. "I now have no tumors," Jones told the newspaper. Stage four melanoma refers to skin cancer that has metastasized to other parts of the body. Jones said he was diagnosed in 2010 and began treatment. Over the next decade, he said, he had two lung surgeries and two lymph node surgeries. He began the experimental therapy near the end of the 10-year period with PD-1, or Pogrammed Cell Death Protein 1, a type of immunotherapy that according to the American Cancer Society helps "the immune system recognize and attack cancer cells." The often outspoken Jones is one of the NFL's most recognizable owners. The Netflix series documents his purchase of the Cowboys in 1989, the firing of iconic coach Tom Landry, Jones's hiring of Jimmy Johnson and the team's glittering successes in the 1990s -- when the Cowboys won three Super Bowls between 1992 and 1995.
Sustainability Times
2 days ago
- Sustainability Times
Prostate Cancer Debate Erupts as "Four a Week May Shield, But More Can Harm" According to Massive Chinese Meta-Analysis
IN A NUTSHELL 📊 Researchers explore the potential link between ejaculation frequency and prostate cancer risk. and risk. 🔍 A Chinese meta-analysis examines data from over 55,000 participants, revealing nuanced findings. examines data from over 55,000 participants, revealing nuanced findings. 🏃♂️ Experts emphasize the importance of a healthy lifestyle over ejaculation frequency for cancer prevention. over ejaculation frequency for cancer prevention. 🔬 Future studies aim to refine our understanding of prostate health with advanced research methods. The idea that regular ejaculation might protect against prostate cancer has been a topic of interest for over 50 years. Various studies, particularly those from U.S. cohorts, have supported this hypothesis. However, a recent Chinese meta-analysis offers a more nuanced view. This article examines the current scientific understanding regarding the relationship between ejaculation frequency and prostate cancer prevention. Our exploration is based on the latest data, presented without bias or premature conclusions. The Prevalence of Prostate Cancer Prostate cancer is one of the most commonly diagnosed cancers among men in the United States. Key risk factors include age, family history, and ethnic background, with African American men at higher risk. These factors are largely unchangeable. Thus, identifying lifestyle choices that can mitigate risk is a public health priority. Researchers are keen to discover behavioral elements that might delay or prevent the onset of prostate cancer. A healthy lifestyle, including regular physical activity and a balanced diet, is often recommended as a preventive measure. But what role, if any, does ejaculation frequency play? Recent studies have begun exploring whether lifestyle changes, such as increased physical activity and a healthy diet, could be more effective in reducing prostate cancer risk than ejaculation frequency. Researchers argue that while ejaculation may have some impact, it is unlikely to be as beneficial as other lifestyle interventions. The scientific community continues to debate, seeking a consensus on this complex issue. 'Your Breath Is a Signature': Scientists Reveal Human Breath Is as Unique and Traceable as a Fingerprint Contradictory Data and Limitations A meta-analysis from China, which reviewed 22 studies involving 55,490 participants, provides contrasting insights. It suggests that up to four ejaculations weekly, or about 16 monthly, might offer slight protective benefits. Beyond this, the risk appears to rise again. The reasons for these findings are varied. Factors such as sexually transmitted infections, which become more likely with multiple partners, and hormonal influences like high androgen levels, which can promote prostate cell proliferation, may play a role. Socio-behavioral factors could also be involved. The reliability of these studies is often questioned due to common methodological issues. Participant self-reporting of ejaculation frequency can lead to measurement errors. Additionally, variations in monitoring infections, diet, or anti-inflammatory use can skew results. The absence of a consistent approach to measuring circulating androgens complicates biological interpretations. Given that prostate cancer progresses slowly, even a 15 to 20-year study might be too short to reveal the long-term effects of behaviors adopted in early adulthood. Discover the Top Nutrient-Rich Foods that Can Assist in Your Weight Loss Journey Expert Recommendations and Societal Guidelines Currently, no medical organizations include ejaculation frequency in their prostate cancer prevention guidelines. The European Association of Urology emphasizes more robust evidence for risk reduction through weight loss, regular exercise, and limiting saturated fat intake. Clinicians can reassure patients that an active sex life, when consensual and free from risky behaviors, does not appear harmful to the prostate. It might even offer minor benefits. Experts continue to stress the importance of a comprehensive approach to prostate health. This includes regular screenings and a focus on overall wellness rather than reliance on any single behavior. Lifestyle changes remain the cornerstone of prostate cancer prevention strategies. Encouraging healthy habits can potentially reduce the risk and improve general well-being, making it a more holistic approach to health management. « This brewing habit could silently hurt you »: these common coffee preparation methods directly linked to increased heart disease risk Future Directions in Prostate Cancer Research The ongoing research into prostate cancer prevention highlights the need for more comprehensive studies. Future research should aim to address current limitations by incorporating more precise methods of data collection and analysis. Long-term studies that track individuals from early adulthood are essential to understand better the impact of lifestyle choices on prostate cancer risk. Additionally, examining a broader range of factors, such as genetics and environmental influences, could provide greater insight. The scientific community is also exploring new technologies and methodologies that could enhance research quality. Advances in genetic testing and biomarker identification may offer new avenues for understanding prostate cancer risk. As research evolves, so too will the strategies for prevention, potentially leading to more personalized approaches based on individual risk profiles. As the scientific community continues to explore the complex relationship between ejaculation frequency and prostate cancer, questions remain. How will future studies reshape our understanding of prostate cancer prevention? Can lifestyle modifications become a cornerstone of risk reduction? The answers may redefine how we approach men's health in the coming decades. This article is based on verified sources and supported by editorial technologies. Did you like it? 4.7/5 (24)
France 24
2 days ago
- France 24
New cancer plan urged as survival improvements in England slow
The study, conducted by the London School of Hygiene and Tropical Medicine, measured the survival index for 10.8 million adults diagnosed with cancer between 1971 and 2018, accounting for variables like age, sex, and cancer type. It found substantial improvements over the 48-year period, with the five-year survival index increasing from 28.8 percent in 1971–72 to 56.6 percent in 2018. However, the pace of progress has slowed in recent years. The 10-year survival index improved by four percent between 2000–01 and 2005–06 and only 1.4 percent between 2010–11 and 2015–16. The slowdown since 2010 "is likely to be at least partly explained by longer waits for diagnosis and treatment," said the report. The deceleration has been observed across many individual cancers, "implying a system-wide challenge," said the study, funded by the Cancer Research UK charity. Most notably, the 10-year survival index for breast, cervix, rectum, prostate, testis, and uterus cancers plateaued in the last 10–15 years, while the index for larynx cancers decreased. Pancreatic cancer survival, at 4.3 percent in 2018, has shown minimal change since 1971–72. The study calls for a "new, long-term National Cancer Plan" to "bring cancer survival trends back towards the best in the world". National cancer strategies have been part of health policy in England and Wales since 2000. The fourth national cancer strategy was published in 2015 but is now considered outdated as the current trajectory has failed to match its ambitious targets. Plans for a fifth plan were withdrawn in January 2023, "leaving England as one of the few high-income countries in which a national cancer plan was not a central pillar of national health policy," said the report.
